CS269021B1 - Esters of carbanilic acid and method of their preparation - Google Patents
Esters of carbanilic acid and method of their preparation Download PDFInfo
- Publication number
- CS269021B1 CS269021B1 CS882965A CS296588A CS269021B1 CS 269021 B1 CS269021 B1 CS 269021B1 CS 882965 A CS882965 A CS 882965A CS 296588 A CS296588 A CS 296588A CS 269021 B1 CS269021 B1 CS 269021B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- esters
- carbanilic
- preparation
- chloride
- butyloxycarbaniloyloxy
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Riešenie sa týká esterov kyseliny karbanilovej všeobecného vzorca I, a tol 1- [2-/2-butyloxykerbaniloyloxycYkloheptyl/ metyl] piperidiniumchloridu a (2-/2;-butyloxykarbaniloyloxy/bornán-3-ylmetylJ dietylamóniumchloridu a sposobu přípravy týchto zlúčenín reakciou 2-butyloxyfenylizokyanátu so zlúčeninou vybranou zo súboru zahrňujúceho 2-piperidinometylcykloheptanol a 3-dietylaminometyl-2-bornanol v toluene pri teplote varu tohoto rozpúštadla počas 12 h.The solution relates to carbanilic esters of formula I, and tol 1- [2- (2-Butyloxycarbaniloyloxycycloheptyl) methyl] piperidinium chloride and (2- (2-butyloxycarbaniloyloxy) boron-3-ylmethyl) diethylammonium chloride and a method of preparation of these compounds by reaction of 2-butyloxyphenyl isocyanate with a compound selected from the group comprising 2-piperidinomethylcycloheptanol and 3-diethylaminomethyl-2-bornanol in toluene at the boiling point of the solvent for 12 h.
Description
CS 269021 31 1 /1/CS 269021 31 1/1 /
Vynález sa týká esterov kyseliny karbanilovej všeobecného vzorca I o-ch2/ch2/2ch3 R-O-CO-HN- kde R znamená cn2-hBACKGROUND OF THE INVENTION The present invention relates to carbanilic acid esters of the formula I-O-CH 2 / CH 2 / CH 3 R-O-CO-HN- wherein R is cn 2 -h
Cl (Ia) alebo ©Cl (Ia) or ©
Ch2-N/C2h5/2 (Ib)Ch2-N / C2h5 / 2 (Ib)
Cl a sposobu príoravy týchto esterov kyseliny karbanilovej. Niektoré zlúčeniny zo skupinyesterov kyseliny karbanilovej sa vyznačujú vysokou lokálno anestetickou aktivitou /Kar-bizokain, Heptakain, Pentakain/ a v niektorých prípadoch aj antidisrytmickou a antilu-ceróznou aktivitou, Zlúčeniny, ktoré sú predoetom vynálezu sú látky nové, doteraz v che-mickej literatúre neopisané. U týchto zlůčenín sa zistili mimoriadne vysoké, doteraz ne-známe lokálno anestetické účinky na organizmus. Pre porovnanie uvádzame tabulke 1 inde-xy lokálno anestetickej aktivity a toxicitu připravených esterov kyseliny karbaniloveja strukturálně blizkej vysoko účinnej zlúčeniny Karbizokainu, ktorého hodnoty sú prebra-té z práce Tůmová I., Švec P. Drugs txptl. clin.Res. 12,845 /1985/. V príkladoch sú uve-dené zlúčeniny, ktoré sú predmetom vynálezu, ako aj sposob ich přípravy spolu s charak-terizáciou týchto zlůčenín. Okrem výfažkov, výsledkov elementárnej prvkovej analýzy,C1 and the method of making these carbanilic acid esters. Some compounds of the carbanilic acid ester groups are characterized by high local anesthetic activity (Carbizocaine, Heptacaine, Pentacain) and in some cases also by anti-arrhythmic and antileacous activity, The compounds of the invention are novel substances not previously described in chemical literature. . These compounds have been found to have extremely high, hitherto unknown, local anesthetic effects on the body. For comparison, Table 1 shows the local anesthetic activity and toxicity of the prepared carbanilic acid esters and the structurally close high-potency compound Carbizocaine, the values of which are presented in Tůmová I., Švec P. Drugs txptl. clin.Res. 12,845 (1985). In the examples, the compounds of the invention as well as the methods for their preparation are described together with the characterization of these compounds. In addition to the extracts, the results of elementary element analysis,
Rp hodnSt /Tenké vrstvy Silufol Ur 356,silikaoél, vyvíjacia sústava cyklohexán - benzén - dietylamín /45: 11: 3/, detekcia pod UF žiarením/ sú uvedené aj IC spektrálné charakte ·· 1 T p* ristiky /chloroform, V v cm / a H NMR spektrálné charakteristiky /chemický posun dv ppm/.Values / Thin Films Silufol Ur 356, silica gel, cyclohexane-benzene-diethylamine / 45: 11: 3 /, detection under UF radiation / IC spectral characteristics are also listed 1 T p ristics / chloroform, V in cm and 1 H NMR spectral characteristics / chemical shift of 2 ppm /.
Na stanovenie lokálno anestetickej aktivity sa použila metoda, ktorej princip spo-čívá V zisíovani ekviefektívnej koncentrácií látky a standardu. Index lokálno anestetic-kej aktivity pri povrchovej aplikácii sa zisťoval na rohovke králíka, standard kokainium -2 -3 chlorid, c= 10 mol.co a index lokálno anestetickej aktivity pre intiltračnej apliká- - -2 —3 cii sa zistoval na koži chrbta morčiat, standard prokaíniumchlorid c= 2.10 mol.dm .Akútna toxicita LO-θ /v mg.kg”^/ sa stanovila na myšiach pri subkutánnej aplikácii.To determine the local anesthetic activity, a method was used, the principle of which is to detect the effective concentration of the substance and the standard. Topical topical anesthetic activity index was measured on the cornea of the rabbit, cocaine standard -2-3 chloride, c = 10 mol.co, and local anesthetic activity index for intiltration - -2 - 3 cii was found on the skin of the guinea pig back , standard procainium chloride c = 2.10 mol.dm. The acute toxicity of LO-θ / in mg.kg-1 was determined in mice by subcutaneous administration.
Postup přípravy esterov kyseliny karbanilovej vyznačuje sa tým, že reaguje 2-buty-loxyfenylizokyanát so zlúčeninou vybranou zo súboru zahrňujúceho 2-piperidinometylcyklo-heptanpl a 3-dietylaminometyl-2-bornanol v toluéne, pri teplote varu tohoto rozpušfadlapo dobu 12 h. CS 259021 BlThe process for preparing carbanilic esters is characterized in that 2-butyloxyphenyl isocyanate is reacted with a compound selected from the group consisting of 2-piperidinomethylcyclo-heptane and 3-diethylaminomethyl-2-bornanol in toluene at the boiling point of this solvent for 12 hours.
Tabulka 1. Lokálno anestetická aktivita a toxicita připravených esterov kyseliny karba-nilovej a Strukturálně blízkého Karbizokainu Lá tkaTable 1. Local anesthetic activity and toxicity of prepared carbalinic and structurally close carbizocaine esters.
Index lokálno anestetickej aktivityinfiltrač.anestéza povrchová anestézaLocal anesthetic activity index infiltration.anesthesia superficial anesthesia
Toxicita/mg.kg-1/Toxicity / mg.kg-1 /
Karbizokain 416 I a/ 232 I b/ 25 251 709 568 380 100 100Carbizocaine 416 I a / 232 I b / 25 251 709 568 380 100 100
Nasledujúce příklady bližšie osvetlujú, ale nijako neobmedzujú sposob pripravy no-vých biologicky aktivnych esterov kyseliny karbanilovej podlá vynálezu. Přiklad 1The following examples illustrate, but do not limit, the preparation of the novel biologically active carbanilic acid esters of the present invention. Example 1
Zmes 0,0091 mol 2-piperidinometylcykloheptanolu, 0,0090 mol 2-butyloxyfenylizokyaná-o tu a 15 cm bezvodého toluénu sa 12 h zahrieva pod spStným tokom, za vylúčenia atmosfe-rickaj vlhkosti. Po ochladeni sa do zmesi přidá 15 cm hexánu a vylúčená tuhá látka/symetricky substituovaná močovina/ sa odfiltruje. Z filtrátu sa za atmosferického, kukonců za zníženého tlaku vydestiluje rozpúšfadlo a nezreegované východiskové zlúčeniny. 3A mixture of 2-piperidinomethylcycloheptanol (0.0091 mol), 2-butyloxyphenylisocyanate (0.0090 mol) and toluene (15 cm) was heated under reflux for 12 h, avoiding atmospheric moisture. After cooling, 15 cm of hexane are added to the mixture and the precipitated solid / symmetrically substituted urea is filtered off. The solvent and unreacted starting materials are distilled off from the filtrate under atmospheric, low-vacuum under reduced pressure. 3
Kvapalný zvyšok sa rozpustí v 20 cm éteru a tento roztok sa dvakrát extrahuje v oddelo- 3 vacom lieviku do 150 cm 5 % -ej.kyseliny chlorovodlkovej. Vylúčená tuhá látka sa odfil-truje, premyje malým objemom vody a přečisti sa kryštalizáciou z vody. Ziska sa 1-- j^2-/2-butyloxykarbaniloyloxycykloheptyl/mety]J piperidiniumchlorid vo výtažku 54 %teorie. Bezfarebné kryštály t.t. 167 - 169 °C, Rp= 0,27 a 0,44 /dve Skvrny, zmes dvochizomérov cis- a trans-/.The liquid residue is dissolved in 20 cm @ 3 of ether and this solution is extracted twice in a separatory funnel to 150 cm @ 3 of 5% strength hydrochloric acid. The precipitated solid is filtered off, washed with a small volume of water and purified by crystallization from water. 1- [2- (2-Butyloxycarbaniloyloxycycloheptyl) methyl] piperidinium chloride is obtained in a yield of 54% of theory. Colorless crystals, m.p. 167-169 ° C, Rp = 0.27 and 0.44 / two spots, a mixture of cis- and trans-.
Analýza pre c24H3gN2°3C1 /M.r.j« 439,04/ vypočítané s 75,57 % C, 11.83 % H, 5,87 % N, zistené: 75,39 % C, 12,03 % H, 5,80 % Nj IC - spektrálné charakteristiky /N-H/ 3427, V /$Ή/ 2448, V /0=0/ 1725, 7 /0=0/ 1604, cf /C-N-H/ 1520. *Η NMR spektrálné charakte-© ristiky CH3 /alkoxyskupina/ 1,02, CH20 4,07, NH-CO 7,27, NH 12,00. Indexy lokálno anes-tetickej aktivity 232 /pri infiltrečnej aplikácii/ 709 / při povrchovej aplikácii,lo5O= 100. Přiklad 2N, 5.87. Found: C, 75.39; H, 12.03; N, 5.80. Found: C, 75.57; - spectral characteristics / NH / 3427, V / $ Ή / 2448, V / 0 = 0/1725, 7/0 = 0/1604, cf / CNH / 1520. * Η NMR spectral characteristics of CH3 / alkoxy / 1 , 02, CH 2 O 4.07, NH-CO 7.27, NH 12.00. Local anesthetic activity indices 232 (in infiltration) (709) at topical application, lo5O = 100. Example 2
Zmes 0,0091 mol 3-dietylaminometyl-2-bornanoiu, 0,0090 mol 2-butyloxyfenylizokyaná- 3 ' tu a 15 cm bezvodého toluénu sa 12 h zahrieva pod spStným tokom, za vylúčenia atmosfe-3 rickej vlhkosti. Po ochladeni sa do zmesi přidá 15 cm hexánu a Vylúčená tuhá látka/symetricky substutuovaná močovina/ sa odfiltruje. Z filtrátu sa za atmosferického, ku konců za zníženého tlaku vydestilujú nezreagované východiskové zlúčeniny. Kvapalný zvy-3 šok sa rozpust! v 20 cm éteru a tento roztok sa v oddelovacom lieviku dvakrát extrahu- 3 je do 200 cm 5 % -ej kyseliny chlorovodlkovej. Vodná vrstva sa oddeli, přefiltruje sacez skládaný filter a přidá sa za miešania a chladenia po častiach 10 %-ný vodný roztokhydroxidu sodného tak, aby teplota zmesi neprestúpiia 20°C na pH= 9. Vylúčený olej saextrahuje trikrát do éteru. Éterová vrstva sa vysuš! nad bezvodým uhličitanom sodným apo filtrácii sa vydestiluje éter. Zvyšky vlhkosti sa odstránia azeotropickou destiláciouolejovitého zvyšku s toluénom. Získaný olej sa rozpustí v 15 cm bezvodého éteru a při-dá sa do zákalu éterový roztok chlorovodika tak, aby teplota zmesi neprestúpiia 0°C.Vylúčená tuhá látka sa odfiltruje a přečisti s.a kryštalizáciou z butanónu. Získá ,sa £2-/2-butyloxykarbaniloyloxy/bornán-3-ylmetylJ dietylamóniumchlorid /11/ vo výfažku69 % teorie. Bezfarebné kryštály t.t. 152 - 154°Cj Analýza pre C26H43N202Cl /M.r. ·457.19/ vypočítané! 66,84 % C. 9,30 % H, 6,00 % N, zistené! 66,29 % C, 9,34 % H, 5,70 %Nj IC - spektrálné charakteristiky P /N-H/ 3424, p/$-H/ 2448,7/0=0/ 1726, Ý /0=0/ 1603,cT /C-N-H/ 1517. ^H NMR spektrálné charakteristiky CHgO 4,08, NH-CO 7,26, $4 11,80.The mixture of 0.0091 mol of 3-diethylaminomethyl-2-bornanoic acid, 0.0090 mol of 2-butyloxyphenylisocyanate and 15 cm @ 3 of anhydrous toluene was heated under reflux for 12 h, avoiding atmospheric humidity. After cooling, 15 cm of hexane are added to the mixture and the precipitated solid / symmetrically substituted urea is filtered off. Unreacted starting materials are distilled off from the filtrate at atmospheric, under reduced pressure. Liquid zvy-3 shock to dissolve! in 20 cm @ 3 of ether and this solution in a separatory funnel twice extracted into 200 cm @ 3 of 5% hydrochloric acid. The aqueous layer was separated, filtered through a padded filter, and 10% aqueous sodium hydroxide solution was added portionwise with stirring and cooling, so that the temperature of the mixture did not exceed 20 ° C to pH = 9. Extracted oil was extracted three times into ether. Dry the ether layer. ether is distilled over anhydrous sodium carbonate and filtered. Moisture residues are removed by azeotropic distillation of the oily residue with toluene. The oil obtained is dissolved in 15 cm @ 3 of anhydrous ether and ethereal hydrochloric acid solution is added to the mixture so that the temperature of the mixture does not exceed 0 DEG C. The precipitated solid is filtered off and purified by crystallization from butanone. There was obtained 2- (2-butyloxycarbaniloyloxy) boron-3-ylmethyl] diethylammonium chloride (11) in a yield of 69% of theory. Colorless crystals, m.p. 152-154 ° C Analysis for C 26 H 43 N 2 O 2 Cl / M · r. 457.19 / calculated! % H, 9.64; N, 6.00; % C, 9.34%, N, 5.70% IC, spectral characteristics P / NH / 3424, p / $ - H / 2448.7 / 0 = 0/1726, Ý / 0 = 0/1603 1 H NMR spectral characteristics CH 3 O 4.08, NH-CO 7.26, $ 4 11.80.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS882965A CS269021B1 (en) | 1988-05-03 | 1988-05-03 | Esters of carbanilic acid and method of their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS882965A CS269021B1 (en) | 1988-05-03 | 1988-05-03 | Esters of carbanilic acid and method of their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CS296588A1 CS296588A1 (en) | 1989-08-14 |
CS269021B1 true CS269021B1 (en) | 1990-04-11 |
Family
ID=5368371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS882965A CS269021B1 (en) | 1988-05-03 | 1988-05-03 | Esters of carbanilic acid and method of their preparation |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS269021B1 (en) |
-
1988
- 1988-05-03 CS CS882965A patent/CS269021B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS296588A1 (en) | 1989-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2032680C1 (en) | Method for production of benzhydryloxyethylpiperazine derivatives | |
SU1660579A3 (en) | Method for obtaining derivatives of isoindolinone or their salts | |
CH652398A5 (en) | THIAZOLIDINDION DERIVATIVES, PRODUCTION OF THESE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
US4370329A (en) | Piperazine derivatives as circulation-enhancing substances | |
GB1567958A (en) | Piperazine and piperazine homologue derivatives and preparation and use thereof | |
JPS6340784B2 (en) | ||
JPH0615527B2 (en) | Alkyldiamine derivative, production method thereof and antiarrhythmic agent | |
CS269021B1 (en) | Esters of carbanilic acid and method of their preparation | |
CA1240326A (en) | 2-(.omega.-ALKYLAMINOALKYL)-AND 2-(.omega.-DIALKYLAMINOALKYL)- 3-(4-X-BENZYLIDEN)-PHTALIMIDINES | |
US4181657A (en) | 2-Aminooctahydroindolo[2,3-a]quinolizines useful in treating cardiovascular disorders | |
US4438143A (en) | 1-Aryloxy-3-alkylamino-2-propanols and pharmaceutical compositions containing them | |
IE47194B1 (en) | Derivatives of amino-alcohols | |
CA2030112A1 (en) | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same | |
CA1065894A (en) | Phenoxypropanolamines | |
GB1580227A (en) | Piperazine derivatives | |
US4206217A (en) | 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds | |
US3317526A (en) | Omega-tertiaryamino butynol-1-phenylcycloalkane carboxylates | |
FI74272B (en) | FOERFARANDE FOER FRAMSTAELLNING AV FARMAKOLOGISKT AKTIV 1- (ACYLAMINOARYLOXI-2-HYDROXI-3-ALKINYLAMINOPROPAN). | |
GB2178035A (en) | Novel benzamides and their preparation and therapeutic application | |
FI73665C (en) | PROCEDURE FOR THE PHARMACOLOGICAL PROPERTIES OF 1- (2-CYANO-ACYLAMINO-PHENYLOXY) -3- (2-METHYLBUTINYL-2) -2-PROPANOLER. | |
FI82457B (en) | FOERFARANDE FOER FRAMSTAELLNING AV THERAPEUTISKT ANVAENDBAR KRISTALLFORM ÇAÇAV 1-BENZHYDYL-4 -ALLYLPIPERAZINDIHYDROKLORID. | |
CA1295617C (en) | 1-¬(1,1-diphenyl)-1-alkenyl| pierazine derivatives, method of preparation and pharmaceutical compositions in which they are present | |
FI76784B (en) | PROCEDURE FOR FRAMSTATION OF PHARMACOLOGICAL PROPERTIES OF 1-PHENOXY-3-ALKINYLAMINO-2-PROPANOLER. | |
KR850000699B1 (en) | Process for preparing 1-(acylamino-aryloxy)-2-hydroxy-3-alkinyl-aminopropanes | |
DE2934450C2 (en) | N- (trimethoxybenzyl) piperazine derivatives and their salts, processes for their preparation and pharmaceuticals |